Viewing Study NCT06299202

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 3:40 AM
Ignite Modification Date: 2026-03-07 @ 10:57 PM
Study NCT ID: NCT06299202
Status: RECRUITING
Last Update Posted: 2024-09-27
First Post: 2024-02-19
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: Contrast-enhanced Spectral Mammography (CESM) Early Quantitative Evaluation of Tumoral Response and Pathologic Complete Response Prediction for Localized Breast Cancer Treated by Neoadjuvant Chemotherapy
Sponsor: Hospices Civils de Lyon
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Breast Cancer View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Breast cancer View
None Contrast Enhanced Spectral Mamography View
None Neodjuvant chemotherapy View
None Quantitative analysis View
None Complete histological response View